---
schema_version: "secwatch.filing_event.v1"
accession: "0001681622-25-000013"
form_type: "8-K"
ticker: "VREX"
cik: "0001681622"
company_name: "Varex Imaging Corp"
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:41:54.815688+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Varex Q1 FY2025 revenue up 5% YoY to $200M; GAAP net loss $0.01/sh, Non-GAAP EPS $0.07

## Summary
- Medical segment revenue $145M (+3% YoY); Industrial segment revenue $55M (+10% YoY).
- Non-GAAP gross margin improved to 35% from 31% in prior-year quarter.
- Cash flow from operations $10M; cash & securities $219M vs $213M at FY2024 year-end.
- Q2 FY2025 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.20.
- CEO cited solid demand and favorable sales mix driving higher-than-expected profitability.

## SEC filing metadata
- accession: 0001681622-25-000013
- form_type: 8-K
- ticker: VREX
- cik: 0001681622
- company_name: Varex Imaging Corp
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681622/000168162225000013/0001681622-25-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681622/000168162225000013/vrex-20250206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001681622-25-000013
- JSON: https://secwatch.observer/filing/0001681622-25-000013.json
- Plain text: https://secwatch.observer/filing/0001681622-25-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.